Classification of Tumors with Unknown Origin
Prediction of tumors in cancers of unknown primary
Cancer Origin Identification
Rayca has developed an innovative approach to classify tumors with unknown origins and primary sites by utilizing gene expression data. Through the analysis of more than 50,000 genes expressed in a patient’s blood sample, Rayca’s technology can identify patterns in biomarkers that offer critical insights into the tumor’s growth rate and potential. By leveraging data pipelines and AI technology, this genetic data can be efficiently and accurately analyzed. Without the support of AI, the process of sorting through vast amounts of data would be inefficient and time-consuming.
Rayca Precision
Technical Specifications
With access to more complex data, our AI system will make new discoveries in detecting the origin of tumors
Advanced Tumor Classification Implemented through AI and Biomarkers
Prediction of Tumors in Cancers of Unknown Primary (CUP)
Assisting Treatment Planning and Monitoring
Quick and Accurate Classification of 40 Tumor Types
Clinical Insights
This solution aims to classify tumors with an unknown origin and primary based on gene expression data. The package provides general information on the gene expression levels of cancer patients and their molecular profile. This information can be valuable for identifying the type of cancer, making treatment decisions, gaining an overall understanding of the patient’s condition, planning treatment, and monitoring patients on a molecular level.
Prediction of Tumors in Cancers of Unknown Primary (CUP)
Instead of obtaining a physical sample of the tumor, we collect its expression data and use it to predict its origin. For instance, if a tumor is observed in the lung but its origin is unknown, we can use our model to predict where it may have originated based on its expression profile.
Molecular Matching of Blood Cancers
A profile of essential differentially expressed genes with graphs (Volcano Plot, Bar Plot, and Condition Description) is presented. Some gene expression levels are critical in all types of cancer. This report provides a gene profile, and the results will be given to the oncologist for further information and treatment decision making. Additionally, a report with a description of significantly differentially expressed genes will be provided.
Pathway Enrichment Analysis Will Be Reported To The Oncologists
Important cancer-related pathways are listed here. Those with significant deregulation will be reported to the oncologist. A description of the patient’s overall condition based on the deregulated pathway will be provided. All pathways with deregulated genes will be reported, and a summary of the condition will be given for each pathway deregulation.
With accuracy and speed, patients will be provided with the best case scenario for a successful treatment plan.
More Capabilities
You might also be interested in these features
Tumor Origin Detection
Classification of Tumors with Unknown Origin
Molecular Staging and Metastasis
Tumor Profiling
Prognosis Analysis and Patient Monitoring
Survival Prediction
Drug Response Prediction
Drug Pairs & Single Drug Response
Frequently Asked Questions
If you have any questions regarding the technical or operational aspects of our services that are not covered in the FAQ, please do not hesitate to contact us. Our support team will get in touch with you as soon as possible.
Operational
It will take only up to 72 hours to fully process the orders, and the results will be delivered to you. The brief scientific reports, as well as necessary supplemental files, will be available for you to download in your highly secure portal.
For most orders, it will take much less than 24 hours to be processed.
All orders must be placed through the Rayca Precision Portal, which is accessible via “portal.raycabio.com”. If you are not yet a verified user and do not have login credentials, kindly send a request for account activation. We will activate your account and send you the login credentials shortly.
Rayca Precision only offers services to healthcare professionals and medical practitioners. Furthermore, all of our services require the supervision of medical professionals and scientists to be applied to clinical settings and decision-making processes.
If you are a patient who is interested in having Rayca Precision solutions applied to your clinical decision-making process, please contact your healthcare provider or doctor and express your interest in Rayca Precision Solutions. They can then reach out to us directly.
Additionally, you can ask our team to check if Rayca Precision has any partnerships with your healthcare provider. In this case, we can assist you in establishing negotiations with your provider and ensuring that Rayca solutions will be applied to your treatment and clinical decision-making process under the supervision of your doctor.
Rayca Precision offers its solutions to any healthcare provider and research institutes, including hospitals, private practitioners, laboratories, sequencing centers, as well as cellular and molecular biology departments.
No! Rayca Precision specializes in running complex computations on patient data to extract high-level insights and make precise predictions on the patients’ clinical outcomes in order to design the most efficient treatment plan. All the required data comes from hospitals, clinical research centers, medical laboratories, and authorized affiliates of our partners who are the providers of the aforementioned patient data.
Technical
Rayca Precision accepts FASTQ files (Raw Sequencing Files) for any type of analysis requested by the user. Additionally, we also accept processed files such as count matrices.
Not at all! No preprocessing needs to be done on the data. Rayca requires the raw FASTQ files. All processing steps, including alignment, quality control, variant calling, variant annotation, and downstream analysis, will be performed in an automated workflow within Rayca’s precision data processing pipelines. Finally, the annotated data points will be ready for machine learning predictions.
Yes, Rayca Precision provides you with access to end-to-end encrypted storage to upload your sequencing data. This is a free service for all Rayca Precision clients and will not cost you any additional fees.
Yes! Rayca Precision grants you access to a secure portal to manage your Rayca account.
You are able to manage your orders, payments, invoices, and the results of your orders (analytical reports, files, scientific documents, etc.) all in one place using our highly secure web application portal.
To access the secure dashboard, you need to have an activated Rayca account and orders. If you have not yet activated your Rayca account, you can easily submit your account activation request. We will activate your account within 24 hours and send you the login credentials shortly thereafter.
